Jagsonpal Pharmaceuticals Limited — Call Transcript 2024

Oct 24, 2024

A CSR Initiative

==> picture [50 x 28] intentionally omitted <==

JAGSONPAL PHARMACEUTICALS LIMITED

==> picture [39 x 48] intentionally omitted <==

Corporate Office: Nimai Tower, 3[rd] Floor, Plot No. 412-415, Phase-IV, Udyog Vihar, Gurugram -122015, Haryana (India)

October 24, 2024

The Department of Corporate Services- Listing The Department of Corporate Services- Listing BSE Ltd, National Stock Exchange of India Ltd Phiroze Jeejeebhoy Towers, Exchange Plaza, C-1, Block G, Dalal Street Bandra Kurla Complex, Bandra Mumbai-400 001 (E) Mumbai – 400 051 Scrip Code: 507789 Symbol: JAGSNPHARM

Subject: Audio Recording of Jagsonpal Pharmaceuticals Limited Q2 FY25 and H1 FY25 Earnings Conference Call on October 24, 2024 at 11:00 AM

Dear Sir/ Madam,

In continuation to our earlier intimation dated October 16, 2024, Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, the audio recording of the Jagsonpal Pharmaceuticals Limited Q2FY25 Earnings Conference Call held on October 24, 2024 at 11:00 AM for discussion of Q2FY25 & H1FY25 Financial Results is available on the Company’s website at below link:

https://www.jagsonpal.com/investor-relations/earning-calls/

We request you to take the above on record.

Thanking you,

For Jagsonpal Pharmaceuticals Limited

ABHISHEK JOSHI

Digitally signed by ABHISHEK JOSHI Date: 2024.10.24 16:27:01 +05'30'

Abhishek Joshi

Company Secretary & Compliance Officer

Ph.: +91 124 4406710; E-mail: cs@jagsonpal.com; Website: www.jagsonpal.com CIN NO. L74899DL1978PLC009181

Regd. Office: T-210 J, Shahpur Jat, New Delhi - 110049 (India)